We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive and Open Surgery in Colon Cancer Show Similar Outcomes

By HospiMedica staff writers
Posted on 03 Jun 2008
Painful general surgery and lengthy healing times could be unnecessary when treating colorectal cancer patients, according to a new review of studies.

Researchers at Namsos Hospital (Norway) searched The Cochrane library, EMBASE, Pubmed, and CancerLit for published and unpublished randomized controlled trials, and conducted a meta-analysis of the combined results of 12 trials involving 3,346 patients; five studies took place in the United States; the others occurred in China, Taiwan, Portugal, Italy, Spain, and the United Kingdom. More...
The reviewers compared outcomes of laparoscopic and open surgeries used in colorectal cancer treatment. The reviewers also evaluated the incidence of adhesions bands of scar tissue that form between organs and tissue and hernias at the incision site, two common complications after colorectal cancer surgery.

The study results found no significant differences between laparoscopic and open surgery in the occurrence of incisional hernias or the number of repeat operations for adhesions. Port-site metastases and wound recurrences were rare and no differences in occurrence after laparoscopic and open surgery were observed; cancer-related mortality at maximum follow-up was similar after laparoscopic and open surgery. No significant difference in tumor recurrence after laparoscopic and open surgery for colon cancer was observed. In colon cancer patients, no significant differences in overall mortality were found. The review was published in the May 2008 issue of The Cochrane Library, a publication of The Cochrane Collaboration (Oxford, United Kingdom), an international organization that evaluates research in all aspects of health care.

"For a long time, many surgeons have been afraid that laparoscopy might impair survival in colorectal cancer patients and cause metastases in the skin openings that are used to insert the instruments, but this has proven not to be the case,” said lead author Esther Kuhry, M.D., a general surgery resident at Namsos.


Related Links:
Namsos Hospital
The Cochrane Collaboration

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.